Live chat at 12 pm ET: last week in CRISPR — cancer, patents, and a dip in the market
oin STAT’s senior science writer, Sharon Begley, for an online chat about the latest developments with the genome-editing technology CRISPR. She’ll take your questions about two new studies raising concerns about whether CRISPR’d cells might become cancerous, about the CRISPR patent wars, and about the ongoing science summarized in STAT’s CRISPR Trackr.
Come back at 12 p.m. ET to enter the chat
Published at Tue, 19 Jun 2018 14:24:19 +0000